CompanyGraph
At a glance
- Depends onDownstream position: depends on 10 industries, supplies 5
- ScaleLevered free cash flow is $24.86M, above the global median of $18.73M
- FinancialsAltman Z-Score 11.23: safe zone
- Interpretations3 currently firing — 3
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
3.79%Above 5Y avg (0.69%)
Annual Rate
GBP 0.06Paid quarterly
Payout Ratio
16.1%Sustainable
Payback Period
14.1 yr
Last Ex-Dividend
May 28, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
470.11MGBP628.02M · vs all stocks (USD)
Trailing P/E
17.56xRevenue (TTM)
129.30MGBP172.73M · vs all stocks (USD)
Profit Margin
21.42%Beta
0.2300xvs all stocks
52-Week Change
-33.89%vs all stocks
Forward Annual Dividend Yield
3.79%vs all stocks
Market Capitalization
470.11MGBP628.02M · vs all stocks (USD)
Enterprise Value
458.54MGBP612.57M · vs all stocks (USD)
Trailing P/E
17.56xForward P/E
15.37xPrice to Sales (TTM)
3.64xPrice to Book (MRQ)
9.13xEnterprise to Revenue
3.55xEnterprise to EBITDA
12.23xProfit Margin
21.42%Operating Margin
30.42%Return on Assets (TTM)
25.56%Return on Equity (TTM)
53.84%Revenue (TTM)
129.30MGBP172.73M · vs all stocks (USD)
Revenue per Share (TTM)
0.4360GBPUpdated Sep 23, 2026Quarterly Revenue Growth
4.20%Gross Profit (TTM)
81.00MGBP108.21M · vs all stocks (USD)
EBITDA (TTM)
44.10MGBP58.91M · vs all stocks (USD)
Net Income (TTM)
27.70MGBP37.00M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-15.10%Operating Cash Flow (TTM)
32.10MGBP42.88M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
18.61MGBP24.86M · vs all stocks (USD)
Forward Annual Dividend Rate
0.0600GBPUpdated Sep 23, 2026Forward Annual Dividend Yield
3.79%vs all stocks
Trailing Annual Dividend Rate
0.1100GBPUpdated Sep 23, 2026Trailing Annual Dividend Yield
6.94%vs all stocks
5-Year Average Dividend Yield
0.69%vs all stocks
Payout Ratio
16.06%Revenue
126.70MGBPFY2025 · Dec 31, 2025Cost of Goods Sold
46.00MGBPFY2025 · Dec 31, 2025Gross Profit
80.70MGBPFY2025 · Dec 31, 2025Operating Income
40.10MGBP53.57M · vs all stocks (USD)
Pre-tax Income
40.10MGBPFY2025 · Dec 31, 2025Income Tax Expense
10.00MGBPFY2025 · Dec 31, 2025Net Income
30.10MGBPFY2025 · Dec 31, 2025EBIT
40.80MGBPFY2025 · Dec 31, 2025EBITDA (Income Statement)
44.10MGBPFY2025 · Dec 31, 2025Selling, General & Administrative
41.00MGBPFY2025 · Dec 31, 2025Non-operating Interest Income
700.00KGBPFY2025 · Dec 31, 2025Non-operating Interest Expense
700.00KGBPFY2025 · Dec 31, 2025EPS (Basic)
0.1019GBPFY2025 · Dec 31, 2025EPS (Diluted)
0.1014GBPFY2025 · Dec 31, 2025Basic Shares Outstanding
295.78MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
295.78MSharesFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00GBPFY2025 · Dec 31, 2025Operating Cash Flow
39.80MGBPFY2025 · Dec 31, 2025Free Cash Flow
39.40MGBPFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
26.40MGBPFY2025 · Dec 31, 2025Starting Profit (CF Statement)
40.10MGBPFY2025 · Dec 31, 2025Stock-based Compensation
1.60MGBPFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-100.00KGBPFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-1.80MGBPFY2025 · Dec 31, 2025Capital Expenditures
-400.00KGBPFY2025 · Dec 31, 2025Net Intangibles (CF)
-5.00MGBPFY2025 · Dec 31, 2025Net Investing Cash Flow
-400.00KGBPFY2025 · Dec 31, 2025Common Stock Repurchase
-900.00KGBPFY2025 · Dec 31, 2025Common Dividends Paid
-26.00MGBPFY2025 · Dec 31, 2025Net Financing Cash Flow
-26.30MGBPFY2025 · Dec 31, 2025Shares Outstanding
296.09MSharesUpdated Sep 23, 2026Float Shares
130.57MSharesUpdated Sep 23, 2026% Held by Insiders
56.41%vs all stocks
% Held by Institutions
29.41%vs all stocks
Total Cash (MRQ)
22.20MGBP29.66M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.0740GBPUpdated Sep 23, 2026Total Debt (MRQ)
9.00MGBP12.02M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1737xCurrent Ratio (MRQ)
1.77xBook Value per Share (MRQ)
0.1730GBPUpdated Sep 23, 2026Total Assets
90.70MGBP121.17M · vs all stocks (USD)
Total Current Assets
45.70MGBPFY2025 · Dec 31, 2025Total Liabilities
39.00MGBPFY2025 · Dec 31, 2025Total Non-current Assets
45.00MGBPFY2025 · Dec 31, 2025Total Non-current Liabilities
10.40MGBPFY2025 · Dec 31, 2025Total Current Liabilities
28.60MGBPFY2025 · Dec 31, 2025Cash
26.40MGBPFY2025 · Dec 31, 2025Cash & Cash Equivalents
26.40MGBPFY2025 · Dec 31, 2025Accounts Receivable
8.50MGBPFY2025 · Dec 31, 2025Accounts Payable
800.00KGBPFY2025 · Dec 31, 2025Short-term Debt
1.20MGBPFY2025 · Dec 31, 2025Long-term Debt
8.10MGBPFY2025 · Dec 31, 2025Common Stock (Book)
300.00KGBPFY2025 · Dec 31, 2025Retained Earnings
58.00MGBPFY2025 · Dec 31, 2025Total Shareholders' Equity
51.70MGBP69.07M · vs all stocks (USD)
Treasury Stock
6.50MGBPFY2025 · Dec 31, 202552-Week Low
140.40GBXUpdated Sep 23, 202652-Week High
246.00GBXUpdated Sep 23, 202652-Week Change
-33.89%vs all stocks
Beta
0.2300xvs all stocks
50-Day MA
163.07GBXUpdated Sep 23, 2026200-Day MA
172.39GBXUpdated Sep 23, 2026Avg 10-Day Volume
610.68KSharesUpdated Sep 23, 2026Avg 30-Day Volume
629.69KSharesUpdated Sep 23, 2026Diluted EPS (TTM)
0.0900GBPUpdated Sep 23, 20263 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
How does this company use capital?
Cash Backing With Revenue And Income Streaks
Revenue has risen in each of three years, profit in all three, and it holds more cash than debt.
Reads
Is this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 11.23: safe zoneNotable
Altman Z-Score: 11.23
High earnings qualityNotable
Earnings Quality Score: 1.05
High structural barrier to entryNotable
Barrier to Entry: 0.78
Supply Chain
Downstream position: depends on 10 industries, supplies 5Notable
Outgoing: 5.00Incoming: 10.00
High connectivity hub: 15 industry connectionsNotable
Total Connections: 15.00
Scale
Levered free cash flow is $24.86M, above the global median of $18.73MNotable
Levered free cash flow (USD): 24,864,438.75Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Zuken Inc.
Tier 1ProductionRecurring-Revenue Lock-InSenseMakingInterface
Enghouse Systems Ltd.
Tier 1ProductionRecurring-Revenue Lock-InInterfaceSenseMaking
Hangzhou Anysoft Information Technology Co., Ltd.
Tier 1ProductionRecurring-Revenue Lock-InFlowInterface
Sansec Technology Co., Ltd.
Tier 1ProductionRecurring-Revenue Lock-InRuleSenseMaking
Beisen Holding Ltd.
Tier 1ProductionRecurring-Revenue Lock-InSenseMakingInterface
Ylz Information Technology Co., Ltd.
Tier 1ProductionRecurring-Revenue Lock-InSenseMakingInterface
Fujian Rongji Software Co., Ltd.
Tier 1ProductionRecurring-Revenue Lock-InSenseMakingInterface
Par Technology Corporation
Tier 1ProductionRecurring-Revenue Lock-InInterfaceFlow
ULG
Tier 1ProductionRecurring-Revenue Lock-InFlowSenseMaking
Jiangxi Tianli Technology Co., Ltd.
Tier 1ProductionRecurring-Revenue Lock-InFlowInterface
Companies that share active interpretations — structural patterns currently present in both stocks.
Zensar Technologies Ltd.
3 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesCash Backing With Revenue And Income StreaksMulti-Year Revenue, Profit, And Income Growth
Tibet Cheezheng Tibetan Medicine Co. Ltd.
3 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesCash Backing With Revenue And Income StreaksMulti-Year Revenue, Profit, And Income Growth
Hamilton Lane Inc.
3 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesCash Backing With Revenue And Income StreaksMulti-Year Revenue, Profit, And Income Growth